Most Recent Articles by Laura Stiles
The US Food and Drug Administration has approved Abilify MyCite, which contains an ingestible sensor that records whether or not the medication was taken.
There is an unmet need for better treatment to manage symptom burden among US adults with ADHD.
Reducing postpartum depression involves universal screening and appropriate referral and treatment by clinicians.
Cognitive reserve in bipolar patients gives a possible explanation for the differences seen among patients in their ability to perform in neurocognitive tests.
Researchers saw improvement in 80% of patients treated with ketamine infusion therapy.